Ericsson Jumps On Attractive Results, And Shares Deserve To Rise Further (NASDAQ:ERIC)
Ericsson Jumps On Attractive Results, And Shares Deserve To Rise Further
Source link
Similar Posts
Linkfest : 23 October, 2024
Some stuff I am reading today morning: Mid, smallcap rally may pause ( BS ) Reliance Infra to set up facility for ammunition ( FE ) Adani to buy Orient Cement ( Rediff ) All big IPOs failed on market debut ( Fortune ) RBI cracking down on Fintechs ( BW ) Problems at Hindenburg…
Don’t Become a Victim of Volatility: Use it to Your Advantage – Fat Tail Daily
At times like this, you have to take a breath and turn off the news! As I told my paid readership group yesterday, this is not the time to become a victim of volatility. Instead, use it to use it to your advantage. The disparity between best-case versus worst-case outcomes in the ‘tariff panic’ is…
Tuesday: Case-Shiller, Durable Goods, Richmond Fed Mfg
by Calculated Risk on 8/25/2025 07:49:00 PM From Matthew Graham at Mortgage News Daily: Mortgage Rates Edge Slightly Higher From Long-Term Lows After last week’s Jackson Hole speech from Fed Chair Powell, rates fell to their lowest levels since October 3rd, 2024, narrowly surpassing the recent long-term low seen on August 13th. Powell tacitly suggested…
Alembic Pharma Shares Rose 2% on USFDA Nod
Shares of Alembic Pharma Ltd rose 2% on Friday, 30 May, after the company announced receiving final approval from the USFDA for its blood cancer drug, Bosutinib Tablets. Earlier on Friday, 30 May, Vadodara-based Alembic Pharmaceuticals Ltd. announced that the U.S. Food and Drug Administration (USFDA) had granted final approval for its Bosutinib Tablets in…
Trading Watch List 10.02.2024
QQQ close below 8 EMA. Seasonality/headline news not favorable for bulls. Expecting some volatility here.QQQ if 477.40 breaks 20/50 comes in play. Follow me on X/Twitter for real time trading setups @szaman and on StockTwits @szaman. Watch us trade these stocks LIVE, in real-time. Click here to get started! Check out our watch list and…
